Vaccine Adjuvants Industry Research Report 2024
Summary
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
According to APO Research, the global Vaccine Adjuvants market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO and Invivogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Adjuvants.
The report will help the Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Adjuvants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Vaccine Adjuvants by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
According to APO Research, the global Vaccine Adjuvants market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO and Invivogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Adjuvants.
The report will help the Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- GSK
- CSL Limited
- Croda
- SEPPIC
- Novavax
- SPI Pharma
- Phibro
- SDA BIO
- Invivogen
- Tj Kaiwei
- OZ Biosciences
- Brenntag Biosector
- MVP Laboratories
- Zhuoyue
- Aphios
- Aluminum Adjuvant
- Emulsions Adjuvant
- Others
- Human Vaccine
- Veterinary Vaccine
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Adjuvants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Vaccine Adjuvants by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Vaccine Adjuvants Market Size (2019-2030) & (US$ Million)
2.2.2 Global Vaccine Adjuvants Sales (2019-2030)
2.2.3 Global Vaccine Adjuvants Market Average Price (2019-2030)
2.3 Vaccine Adjuvants by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Aluminum Adjuvant
2.3.3 Emulsions Adjuvant
2.3.4 Others
2.4 Vaccine Adjuvants by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Human Vaccine
2.4.3 Veterinary Vaccine
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Vaccine Adjuvants Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Vaccine Adjuvants Sales (MT) of Manufacturers (2019-2024)
3.3 Global Vaccine Adjuvants Revenue of Manufacturers (2019-2024)
3.4 Global Vaccine Adjuvants Average Price by Manufacturers (2019-2024)
3.5 Global Vaccine Adjuvants Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Vaccine Adjuvants, Product Type & Application
3.8 Global Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
3.9 Global Vaccine Adjuvants Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 GSK
4.1.1 GSK Company Information
4.1.2 GSK Business Overview
4.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.1.4 GSK Vaccine Adjuvants Product Portfolio
4.1.5 GSK Recent Developments
4.2 CSL Limited
4.2.1 CSL Limited Company Information
4.2.2 CSL Limited Business Overview
4.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
4.2.5 CSL Limited Recent Developments
4.3 Croda
4.3.1 Croda Company Information
4.3.2 Croda Business Overview
4.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Croda Vaccine Adjuvants Product Portfolio
4.3.5 Croda Recent Developments
4.4 SEPPIC
4.4.1 SEPPIC Company Information
4.4.2 SEPPIC Business Overview
4.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
4.4.5 SEPPIC Recent Developments
4.5 Novavax
4.5.1 Novavax Company Information
4.5.2 Novavax Business Overview
4.5.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Novavax Vaccine Adjuvants Product Portfolio
4.5.5 Novavax Recent Developments
4.6 SPI Pharma
4.6.1 SPI Pharma Company Information
4.6.2 SPI Pharma Business Overview
4.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.6.4 SPI Pharma Vaccine Adjuvants Product Portfolio
4.6.5 SPI Pharma Recent Developments
4.7 Phibro
4.7.1 Phibro Company Information
4.7.2 Phibro Business Overview
4.7.3 Phibro Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Phibro Vaccine Adjuvants Product Portfolio
4.7.5 Phibro Recent Developments
4.8 SDA BIO
4.8.1 SDA BIO Company Information
4.8.2 SDA BIO Business Overview
4.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.8.4 SDA BIO Vaccine Adjuvants Product Portfolio
4.8.5 SDA BIO Recent Developments
4.9 Invivogen
4.9.1 Invivogen Company Information
4.9.2 Invivogen Business Overview
4.9.3 Invivogen Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Invivogen Vaccine Adjuvants Product Portfolio
4.9.5 Invivogen Recent Developments
4.10 Tj Kaiwei
4.10.1 Tj Kaiwei Company Information
4.10.2 Tj Kaiwei Business Overview
4.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Tj Kaiwei Vaccine Adjuvants Product Portfolio
4.10.5 Tj Kaiwei Recent Developments
4.11 OZ Biosciences
4.11.1 OZ Biosciences Company Information
4.11.2 OZ Biosciences Business Overview
4.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.11.4 OZ Biosciences Vaccine Adjuvants Product Portfolio
4.11.5 OZ Biosciences Recent Developments
4.12 Brenntag Biosector
4.12.1 Brenntag Biosector Company Information
4.12.2 Brenntag Biosector Business Overview
4.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Brenntag Biosector Vaccine Adjuvants Product Portfolio
4.12.5 Brenntag Biosector Recent Developments
4.13 MVP Laboratories
4.13.1 MVP Laboratories Company Information
4.13.2 MVP Laboratories Business Overview
4.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.13.4 MVP Laboratories Vaccine Adjuvants Product Portfolio
4.13.5 MVP Laboratories Recent Developments
4.14 Zhuoyue
4.14.1 Zhuoyue Company Information
4.14.2 Zhuoyue Business Overview
4.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Zhuoyue Vaccine Adjuvants Product Portfolio
4.14.5 Zhuoyue Recent Developments
4.15 Aphios
4.15.1 Aphios Company Information
4.15.2 Aphios Business Overview
4.15.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Aphios Vaccine Adjuvants Product Portfolio
4.15.5 Aphios Recent Developments
5 GLOBAL VACCINE ADJUVANTS MARKET SCENARIO BY REGION
5.1 Global Vaccine Adjuvants Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Vaccine Adjuvants Sales by Region: 2019-2030
5.2.1 Global Vaccine Adjuvants Sales by Region: 2019-2024
5.2.2 Global Vaccine Adjuvants Sales by Region: 2025-2030
5.3 Global Vaccine Adjuvants Revenue by Region: 2019-2030
5.3.1 Global Vaccine Adjuvants Revenue by Region: 2019-2024
5.3.2 Global Vaccine Adjuvants Revenue by Region: 2025-2030
5.4 North America Vaccine Adjuvants Market Facts & Figures by Country
5.4.1 North America Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Vaccine Adjuvants Sales by Country (2019-2030)
5.4.3 North America Vaccine Adjuvants Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Vaccine Adjuvants Market Facts & Figures by Country
5.5.1 Europe Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Vaccine Adjuvants Sales by Country (2019-2030)
5.5.3 Europe Vaccine Adjuvants Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Vaccine Adjuvants Market Facts & Figures by Country
5.6.1 Asia Pacific Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Vaccine Adjuvants Sales by Country (2019-2030)
5.6.3 Asia Pacific Vaccine Adjuvants Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Vaccine Adjuvants Market Facts & Figures by Country
5.7.1 Latin America Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Vaccine Adjuvants Sales by Country (2019-2030)
5.7.3 Latin America Vaccine Adjuvants Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Vaccine Adjuvants Market Facts & Figures by Country
5.8.1 Middle East and Africa Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Vaccine Adjuvants Sales by Country (2019-2030)
5.8.3 Middle East and Africa Vaccine Adjuvants Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Vaccine Adjuvants Sales by Type (2019-2030)
6.1.1 Global Vaccine Adjuvants Sales by Type (2019-2030) & (MT)
6.1.2 Global Vaccine Adjuvants Sales Market Share by Type (2019-2030)
6.2 Global Vaccine Adjuvants Revenue by Type (2019-2030)
6.2.1 Global Vaccine Adjuvants Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Vaccine Adjuvants Revenue Market Share by Type (2019-2030)
6.3 Global Vaccine Adjuvants Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Vaccine Adjuvants Sales by Application (2019-2030)
7.1.1 Global Vaccine Adjuvants Sales by Application (2019-2030) & (MT)
7.1.2 Global Vaccine Adjuvants Sales Market Share by Application (2019-2030)
7.2 Global Vaccine Adjuvants Revenue by Application (2019-2030)
7.2.1 Global Vaccine Adjuvants Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Vaccine Adjuvants Revenue Market Share by Application (2019-2030)
7.3 Global Vaccine Adjuvants Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Vaccine Adjuvants Value Chain Analysis
8.1.1 Vaccine Adjuvants Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Vaccine Adjuvants Production Mode & Process
8.2 Vaccine Adjuvants Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Vaccine Adjuvants Distributors
8.2.3 Vaccine Adjuvants Customers
9 GLOBAL VACCINE ADJUVANTS ANALYZING MARKET DYNAMICS
9.1 Vaccine Adjuvants Industry Trends
9.2 Vaccine Adjuvants Industry Drivers
9.3 Vaccine Adjuvants Industry Opportunities and Challenges
9.4 Vaccine Adjuvants Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Vaccine Adjuvants Market Size (2019-2030) & (US$ Million)
2.2.2 Global Vaccine Adjuvants Sales (2019-2030)
2.2.3 Global Vaccine Adjuvants Market Average Price (2019-2030)
2.3 Vaccine Adjuvants by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Aluminum Adjuvant
2.3.3 Emulsions Adjuvant
2.3.4 Others
2.4 Vaccine Adjuvants by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Human Vaccine
2.4.3 Veterinary Vaccine
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Vaccine Adjuvants Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Vaccine Adjuvants Sales (MT) of Manufacturers (2019-2024)
3.3 Global Vaccine Adjuvants Revenue of Manufacturers (2019-2024)
3.4 Global Vaccine Adjuvants Average Price by Manufacturers (2019-2024)
3.5 Global Vaccine Adjuvants Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Vaccine Adjuvants, Product Type & Application
3.8 Global Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
3.9 Global Vaccine Adjuvants Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 GSK
4.1.1 GSK Company Information
4.1.2 GSK Business Overview
4.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.1.4 GSK Vaccine Adjuvants Product Portfolio
4.1.5 GSK Recent Developments
4.2 CSL Limited
4.2.1 CSL Limited Company Information
4.2.2 CSL Limited Business Overview
4.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
4.2.5 CSL Limited Recent Developments
4.3 Croda
4.3.1 Croda Company Information
4.3.2 Croda Business Overview
4.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Croda Vaccine Adjuvants Product Portfolio
4.3.5 Croda Recent Developments
4.4 SEPPIC
4.4.1 SEPPIC Company Information
4.4.2 SEPPIC Business Overview
4.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
4.4.5 SEPPIC Recent Developments
4.5 Novavax
4.5.1 Novavax Company Information
4.5.2 Novavax Business Overview
4.5.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Novavax Vaccine Adjuvants Product Portfolio
4.5.5 Novavax Recent Developments
4.6 SPI Pharma
4.6.1 SPI Pharma Company Information
4.6.2 SPI Pharma Business Overview
4.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.6.4 SPI Pharma Vaccine Adjuvants Product Portfolio
4.6.5 SPI Pharma Recent Developments
4.7 Phibro
4.7.1 Phibro Company Information
4.7.2 Phibro Business Overview
4.7.3 Phibro Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Phibro Vaccine Adjuvants Product Portfolio
4.7.5 Phibro Recent Developments
4.8 SDA BIO
4.8.1 SDA BIO Company Information
4.8.2 SDA BIO Business Overview
4.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.8.4 SDA BIO Vaccine Adjuvants Product Portfolio
4.8.5 SDA BIO Recent Developments
4.9 Invivogen
4.9.1 Invivogen Company Information
4.9.2 Invivogen Business Overview
4.9.3 Invivogen Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Invivogen Vaccine Adjuvants Product Portfolio
4.9.5 Invivogen Recent Developments
4.10 Tj Kaiwei
4.10.1 Tj Kaiwei Company Information
4.10.2 Tj Kaiwei Business Overview
4.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Tj Kaiwei Vaccine Adjuvants Product Portfolio
4.10.5 Tj Kaiwei Recent Developments
4.11 OZ Biosciences
4.11.1 OZ Biosciences Company Information
4.11.2 OZ Biosciences Business Overview
4.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.11.4 OZ Biosciences Vaccine Adjuvants Product Portfolio
4.11.5 OZ Biosciences Recent Developments
4.12 Brenntag Biosector
4.12.1 Brenntag Biosector Company Information
4.12.2 Brenntag Biosector Business Overview
4.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Brenntag Biosector Vaccine Adjuvants Product Portfolio
4.12.5 Brenntag Biosector Recent Developments
4.13 MVP Laboratories
4.13.1 MVP Laboratories Company Information
4.13.2 MVP Laboratories Business Overview
4.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.13.4 MVP Laboratories Vaccine Adjuvants Product Portfolio
4.13.5 MVP Laboratories Recent Developments
4.14 Zhuoyue
4.14.1 Zhuoyue Company Information
4.14.2 Zhuoyue Business Overview
4.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Zhuoyue Vaccine Adjuvants Product Portfolio
4.14.5 Zhuoyue Recent Developments
4.15 Aphios
4.15.1 Aphios Company Information
4.15.2 Aphios Business Overview
4.15.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Aphios Vaccine Adjuvants Product Portfolio
4.15.5 Aphios Recent Developments
5 GLOBAL VACCINE ADJUVANTS MARKET SCENARIO BY REGION
5.1 Global Vaccine Adjuvants Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Vaccine Adjuvants Sales by Region: 2019-2030
5.2.1 Global Vaccine Adjuvants Sales by Region: 2019-2024
5.2.2 Global Vaccine Adjuvants Sales by Region: 2025-2030
5.3 Global Vaccine Adjuvants Revenue by Region: 2019-2030
5.3.1 Global Vaccine Adjuvants Revenue by Region: 2019-2024
5.3.2 Global Vaccine Adjuvants Revenue by Region: 2025-2030
5.4 North America Vaccine Adjuvants Market Facts & Figures by Country
5.4.1 North America Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Vaccine Adjuvants Sales by Country (2019-2030)
5.4.3 North America Vaccine Adjuvants Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Vaccine Adjuvants Market Facts & Figures by Country
5.5.1 Europe Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Vaccine Adjuvants Sales by Country (2019-2030)
5.5.3 Europe Vaccine Adjuvants Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Vaccine Adjuvants Market Facts & Figures by Country
5.6.1 Asia Pacific Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Vaccine Adjuvants Sales by Country (2019-2030)
5.6.3 Asia Pacific Vaccine Adjuvants Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Vaccine Adjuvants Market Facts & Figures by Country
5.7.1 Latin America Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Vaccine Adjuvants Sales by Country (2019-2030)
5.7.3 Latin America Vaccine Adjuvants Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Vaccine Adjuvants Market Facts & Figures by Country
5.8.1 Middle East and Africa Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Vaccine Adjuvants Sales by Country (2019-2030)
5.8.3 Middle East and Africa Vaccine Adjuvants Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Vaccine Adjuvants Sales by Type (2019-2030)
6.1.1 Global Vaccine Adjuvants Sales by Type (2019-2030) & (MT)
6.1.2 Global Vaccine Adjuvants Sales Market Share by Type (2019-2030)
6.2 Global Vaccine Adjuvants Revenue by Type (2019-2030)
6.2.1 Global Vaccine Adjuvants Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Vaccine Adjuvants Revenue Market Share by Type (2019-2030)
6.3 Global Vaccine Adjuvants Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Vaccine Adjuvants Sales by Application (2019-2030)
7.1.1 Global Vaccine Adjuvants Sales by Application (2019-2030) & (MT)
7.1.2 Global Vaccine Adjuvants Sales Market Share by Application (2019-2030)
7.2 Global Vaccine Adjuvants Revenue by Application (2019-2030)
7.2.1 Global Vaccine Adjuvants Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Vaccine Adjuvants Revenue Market Share by Application (2019-2030)
7.3 Global Vaccine Adjuvants Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Vaccine Adjuvants Value Chain Analysis
8.1.1 Vaccine Adjuvants Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Vaccine Adjuvants Production Mode & Process
8.2 Vaccine Adjuvants Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Vaccine Adjuvants Distributors
8.2.3 Vaccine Adjuvants Customers
9 GLOBAL VACCINE ADJUVANTS ANALYZING MARKET DYNAMICS
9.1 Vaccine Adjuvants Industry Trends
9.2 Vaccine Adjuvants Industry Drivers
9.3 Vaccine Adjuvants Industry Opportunities and Challenges
9.4 Vaccine Adjuvants Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Vaccine Adjuvants Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Vaccine Adjuvants Sales (MT) of Manufacturers (2018-2023)
Table 7. Global Vaccine Adjuvants Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Vaccine Adjuvants Revenue of Manufacturers (2018-2023)
Table 9. Global Vaccine Adjuvants Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Vaccine Adjuvants Average Price (USD/Kg) of Manufacturers (2018-2023)
Table 11. Global Vaccine Adjuvants Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Vaccine Adjuvants, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccine Adjuvants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. GSK Company Information
Table 17. GSK Business Overview
Table 18. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 19. GSK Vaccine Adjuvants Product Portfolio
Table 20. GSK Recent Developments
Table 21. CSL Limited Company Information
Table 22. CSL Limited Business Overview
Table 23. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 24. CSL Limited Vaccine Adjuvants Product Portfolio
Table 25. CSL Limited Recent Developments
Table 26. Croda Company Information
Table 27. Croda Business Overview
Table 28. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 29. Croda Vaccine Adjuvants Product Portfolio
Table 30. Croda Recent Developments
Table 31. SEPPIC Company Information
Table 32. SEPPIC Business Overview
Table 33. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 34. SEPPIC Vaccine Adjuvants Product Portfolio
Table 35. SEPPIC Recent Developments
Table 36. Novavax Company Information
Table 37. Novavax Business Overview
Table 38. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 39. Novavax Vaccine Adjuvants Product Portfolio
Table 40. Novavax Recent Developments
Table 41. SPI Pharma Company Information
Table 42. SPI Pharma Business Overview
Table 43. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 44. SPI Pharma Vaccine Adjuvants Product Portfolio
Table 45. SPI Pharma Recent Developments
Table 46. Phibro Company Information
Table 47. Phibro Business Overview
Table 48. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 49. Phibro Vaccine Adjuvants Product Portfolio
Table 50. Phibro Recent Developments
Table 51. SDA BIO Company Information
Table 52. SDA BIO Business Overview
Table 53. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 54. SDA BIO Vaccine Adjuvants Product Portfolio
Table 55. SDA BIO Recent Developments
Table 56. Invivogen Company Information
Table 57. Invivogen Business Overview
Table 58. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 59. Invivogen Vaccine Adjuvants Product Portfolio
Table 60. Invivogen Recent Developments
Table 61. Tj Kaiwei Company Information
Table 62. Tj Kaiwei Business Overview
Table 63. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 64. Tj Kaiwei Vaccine Adjuvants Product Portfolio
Table 65. Tj Kaiwei Recent Developments
Table 66. OZ Biosciences Company Information
Table 67. OZ Biosciences Business Overview
Table 68. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 69. OZ Biosciences Vaccine Adjuvants Product Portfolio
Table 70. OZ Biosciences Recent Developments
Table 71. Brenntag Biosector Company Information
Table 72. Brenntag Biosector Business Overview
Table 73. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 74. Brenntag Biosector Vaccine Adjuvants Product Portfolio
Table 75. Brenntag Biosector Recent Developments
Table 76. MVP Laboratories Company Information
Table 77. MVP Laboratories Business Overview
Table 78. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 79. MVP Laboratories Vaccine Adjuvants Product Portfolio
Table 80. MVP Laboratories Recent Developments
Table 81. Zhuoyue Company Information
Table 82. Zhuoyue Business Overview
Table 83. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 84. Zhuoyue Vaccine Adjuvants Product Portfolio
Table 85. Zhuoyue Recent Developments
Table 86. Aphios Company Information
Table 87. Aphios Business Overview
Table 88. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 89. Aphios Vaccine Adjuvants Product Portfolio
Table 90. Aphios Recent Developments
Table 91. Global Vaccine Adjuvants Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 92. Global Vaccine Adjuvants Sales by Region (2018-2023) & (MT)
Table 93. Global Vaccine Adjuvants Sales Market Share by Region (2018-2023)
Table 94. Global Vaccine Adjuvants Sales by Region (2024-2029) & (MT)
Table 95. Global Vaccine Adjuvants Sales Market Share by Region (2024-2029)
Table 96. Global Vaccine Adjuvants Revenue by Region (2018-2023) & (US$ Million)
Table 97. Global Vaccine Adjuvants Revenue Market Share by Region (2018-2023)
Table 98. Global Vaccine Adjuvants Revenue by Region (2024-2029) & (US$ Million)
Table 99. Global Vaccine Adjuvants Revenue Market Share by Region (2024-2029)
Table 100. North America Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. North America Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 102. North America Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 103. North America Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 104. North America Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 105. Europe Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Europe Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 107. Europe Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 108. Europe Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 109. Europe Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 110. Asia Pacific Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Asia Pacific Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 112. Asia Pacific Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 113. Asia Pacific Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 114. Asia Pacific Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 115. Latin America Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Latin America Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 117. Latin America Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 118. Latin America Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 119. Latin America Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 120. Middle East and Africa Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Middle East and Africa Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 122. Middle East and Africa Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 123. Middle East and Africa Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 124. Middle East and Africa Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 125. Global Vaccine Adjuvants Sales by Type (2018-2023) & (MT)
Table 126. Global Vaccine Adjuvants Sales by Type (2024-2029) & (MT)
Table 127. Global Vaccine Adjuvants Sales Market Share by Type (2018-2023)
Table 128. Global Vaccine Adjuvants Sales Market Share by Type (2024-2029)
Table 129. Global Vaccine Adjuvants Revenue by Type (2018-2023) & (US$ Million)
Table 130. Global Vaccine Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 131. Global Vaccine Adjuvants Revenue Market Share by Type (2018-2023)
Table 132. Global Vaccine Adjuvants Revenue Market Share by Type (2024-2029)
Table 133. Global Vaccine Adjuvants Price by Type (2018-2023) & (USD/Kg)
Table 134. Global Vaccine Adjuvants Price by Type (2024-2029) & (USD/Kg)
Table 135. Global Vaccine Adjuvants Sales by Application (2018-2023) & (MT)
Table 136. Global Vaccine Adjuvants Sales by Application (2024-2029) & (MT)
Table 137. Global Vaccine Adjuvants Sales Market Share by Application (2018-2023)
Table 138. Global Vaccine Adjuvants Sales Market Share by Application (2024-2029)
Table 139. Global Vaccine Adjuvants Revenue by Application (2018-2023) & (US$ Million)
Table 140. Global Vaccine Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 141. Global Vaccine Adjuvants Revenue Market Share by Application (2018-2023)
Table 142. Global Vaccine Adjuvants Revenue Market Share by Application (2024-2029)
Table 143. Global Vaccine Adjuvants Price by Application (2018-2023) & (USD/Kg)
Table 144. Global Vaccine Adjuvants Price by Application (2024-2029) & (USD/Kg)
Table 145. Key Raw Materials
Table 146. Raw Materials Key Suppliers
Table 147. Vaccine Adjuvants Distributors List
Table 148. Vaccine Adjuvants Customers List
Table 149. Vaccine Adjuvants Industry Trends
Table 150. Vaccine Adjuvants Industry Drivers
Table 151. Vaccine Adjuvants Industry Restraints
Table 152. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Vaccine Adjuvants Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Vaccine Adjuvants Sales (MT) of Manufacturers (2018-2023)
Table 7. Global Vaccine Adjuvants Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Vaccine Adjuvants Revenue of Manufacturers (2018-2023)
Table 9. Global Vaccine Adjuvants Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Vaccine Adjuvants Average Price (USD/Kg) of Manufacturers (2018-2023)
Table 11. Global Vaccine Adjuvants Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Vaccine Adjuvants, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccine Adjuvants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. GSK Company Information
Table 17. GSK Business Overview
Table 18. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 19. GSK Vaccine Adjuvants Product Portfolio
Table 20. GSK Recent Developments
Table 21. CSL Limited Company Information
Table 22. CSL Limited Business Overview
Table 23. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 24. CSL Limited Vaccine Adjuvants Product Portfolio
Table 25. CSL Limited Recent Developments
Table 26. Croda Company Information
Table 27. Croda Business Overview
Table 28. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 29. Croda Vaccine Adjuvants Product Portfolio
Table 30. Croda Recent Developments
Table 31. SEPPIC Company Information
Table 32. SEPPIC Business Overview
Table 33. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 34. SEPPIC Vaccine Adjuvants Product Portfolio
Table 35. SEPPIC Recent Developments
Table 36. Novavax Company Information
Table 37. Novavax Business Overview
Table 38. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 39. Novavax Vaccine Adjuvants Product Portfolio
Table 40. Novavax Recent Developments
Table 41. SPI Pharma Company Information
Table 42. SPI Pharma Business Overview
Table 43. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 44. SPI Pharma Vaccine Adjuvants Product Portfolio
Table 45. SPI Pharma Recent Developments
Table 46. Phibro Company Information
Table 47. Phibro Business Overview
Table 48. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 49. Phibro Vaccine Adjuvants Product Portfolio
Table 50. Phibro Recent Developments
Table 51. SDA BIO Company Information
Table 52. SDA BIO Business Overview
Table 53. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 54. SDA BIO Vaccine Adjuvants Product Portfolio
Table 55. SDA BIO Recent Developments
Table 56. Invivogen Company Information
Table 57. Invivogen Business Overview
Table 58. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 59. Invivogen Vaccine Adjuvants Product Portfolio
Table 60. Invivogen Recent Developments
Table 61. Tj Kaiwei Company Information
Table 62. Tj Kaiwei Business Overview
Table 63. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 64. Tj Kaiwei Vaccine Adjuvants Product Portfolio
Table 65. Tj Kaiwei Recent Developments
Table 66. OZ Biosciences Company Information
Table 67. OZ Biosciences Business Overview
Table 68. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 69. OZ Biosciences Vaccine Adjuvants Product Portfolio
Table 70. OZ Biosciences Recent Developments
Table 71. Brenntag Biosector Company Information
Table 72. Brenntag Biosector Business Overview
Table 73. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 74. Brenntag Biosector Vaccine Adjuvants Product Portfolio
Table 75. Brenntag Biosector Recent Developments
Table 76. MVP Laboratories Company Information
Table 77. MVP Laboratories Business Overview
Table 78. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 79. MVP Laboratories Vaccine Adjuvants Product Portfolio
Table 80. MVP Laboratories Recent Developments
Table 81. Zhuoyue Company Information
Table 82. Zhuoyue Business Overview
Table 83. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 84. Zhuoyue Vaccine Adjuvants Product Portfolio
Table 85. Zhuoyue Recent Developments
Table 86. Aphios Company Information
Table 87. Aphios Business Overview
Table 88. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 89. Aphios Vaccine Adjuvants Product Portfolio
Table 90. Aphios Recent Developments
Table 91. Global Vaccine Adjuvants Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 92. Global Vaccine Adjuvants Sales by Region (2018-2023) & (MT)
Table 93. Global Vaccine Adjuvants Sales Market Share by Region (2018-2023)
Table 94. Global Vaccine Adjuvants Sales by Region (2024-2029) & (MT)
Table 95. Global Vaccine Adjuvants Sales Market Share by Region (2024-2029)
Table 96. Global Vaccine Adjuvants Revenue by Region (2018-2023) & (US$ Million)
Table 97. Global Vaccine Adjuvants Revenue Market Share by Region (2018-2023)
Table 98. Global Vaccine Adjuvants Revenue by Region (2024-2029) & (US$ Million)
Table 99. Global Vaccine Adjuvants Revenue Market Share by Region (2024-2029)
Table 100. North America Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. North America Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 102. North America Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 103. North America Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 104. North America Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 105. Europe Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Europe Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 107. Europe Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 108. Europe Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 109. Europe Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 110. Asia Pacific Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Asia Pacific Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 112. Asia Pacific Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 113. Asia Pacific Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 114. Asia Pacific Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 115. Latin America Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Latin America Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 117. Latin America Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 118. Latin America Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 119. Latin America Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 120. Middle East and Africa Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Middle East and Africa Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 122. Middle East and Africa Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 123. Middle East and Africa Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 124. Middle East and Africa Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 125. Global Vaccine Adjuvants Sales by Type (2018-2023) & (MT)
Table 126. Global Vaccine Adjuvants Sales by Type (2024-2029) & (MT)
Table 127. Global Vaccine Adjuvants Sales Market Share by Type (2018-2023)
Table 128. Global Vaccine Adjuvants Sales Market Share by Type (2024-2029)
Table 129. Global Vaccine Adjuvants Revenue by Type (2018-2023) & (US$ Million)
Table 130. Global Vaccine Adjuvants Revenue by Type (2024-2029) & (US$ Million)
Table 131. Global Vaccine Adjuvants Revenue Market Share by Type (2018-2023)
Table 132. Global Vaccine Adjuvants Revenue Market Share by Type (2024-2029)
Table 133. Global Vaccine Adjuvants Price by Type (2018-2023) & (USD/Kg)
Table 134. Global Vaccine Adjuvants Price by Type (2024-2029) & (USD/Kg)
Table 135. Global Vaccine Adjuvants Sales by Application (2018-2023) & (MT)
Table 136. Global Vaccine Adjuvants Sales by Application (2024-2029) & (MT)
Table 137. Global Vaccine Adjuvants Sales Market Share by Application (2018-2023)
Table 138. Global Vaccine Adjuvants Sales Market Share by Application (2024-2029)
Table 139. Global Vaccine Adjuvants Revenue by Application (2018-2023) & (US$ Million)
Table 140. Global Vaccine Adjuvants Revenue by Application (2024-2029) & (US$ Million)
Table 141. Global Vaccine Adjuvants Revenue Market Share by Application (2018-2023)
Table 142. Global Vaccine Adjuvants Revenue Market Share by Application (2024-2029)
Table 143. Global Vaccine Adjuvants Price by Application (2018-2023) & (USD/Kg)
Table 144. Global Vaccine Adjuvants Price by Application (2024-2029) & (USD/Kg)
Table 145. Key Raw Materials
Table 146. Raw Materials Key Suppliers
Table 147. Vaccine Adjuvants Distributors List
Table 148. Vaccine Adjuvants Customers List
Table 149. Vaccine Adjuvants Industry Trends
Table 150. Vaccine Adjuvants Industry Drivers
Table 151. Vaccine Adjuvants Industry Restraints
Table 152. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Vaccine AdjuvantsProduct Picture
Figure 5. Global Vaccine Adjuvants Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Vaccine Adjuvants Market Size (2018-2029) & (US$ Million)
Figure 7. Global Vaccine Adjuvants Sales (2018-2029) & (MT)
Figure 8. Global Vaccine Adjuvants Average Price (USD/Kg) & (2018-2029)
Figure 9. Aluminum Adjuvant Product Picture
Figure 10. Emulsions Adjuvant Product Picture
Figure 11. Others Product Picture
Figure 12. Human Vaccine Product Picture
Figure 13. Veterinary Vaccine Product Picture
Figure 14. Global Vaccine Adjuvants Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Vaccine Adjuvants Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Vaccine Adjuvants Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Vaccine Adjuvants Sales by Region in 2022
Figure 21. Global Vaccine Adjuvants Revenue by Region in 2022
Figure 22. North America Vaccine Adjuvants Market Size by Country in 2022
Figure 23. North America Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 24. North America Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Vaccine Adjuvants Market Size by Country in 2022
Figure 28. Europe Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 29. Europe Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 30. Germany Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Vaccine Adjuvants Market Size by Country in 2022
Figure 36. Asia Pacific Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 38. China Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Vaccine Adjuvants Market Size by Country in 2022
Figure 48. Latin America Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 49. Latin America Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Vaccine Adjuvants Market Size by Country in 2022
Figure 54. Middle East and Africa Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Vaccine Adjuvants Sales Market Share by Type (2018-2029)
Figure 60. Global Vaccine Adjuvants Revenue Market Share by Type (2018-2029)
Figure 61. Global Vaccine Adjuvants Price (USD/Kg) by Type (2018-2029)
Figure 62. Global Vaccine Adjuvants Sales Market Share by Application (2018-2029)
Figure 63. Global Vaccine Adjuvants Revenue Market Share by Application (2018-2029)
Figure 64. Global Vaccine Adjuvants Price (USD/Kg) by Application (2018-2029)
Figure 65. Vaccine Adjuvants Value Chain
Figure 66. Vaccine Adjuvants Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Vaccine Adjuvants Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Vaccine AdjuvantsProduct Picture
Figure 5. Global Vaccine Adjuvants Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Vaccine Adjuvants Market Size (2018-2029) & (US$ Million)
Figure 7. Global Vaccine Adjuvants Sales (2018-2029) & (MT)
Figure 8. Global Vaccine Adjuvants Average Price (USD/Kg) & (2018-2029)
Figure 9. Aluminum Adjuvant Product Picture
Figure 10. Emulsions Adjuvant Product Picture
Figure 11. Others Product Picture
Figure 12. Human Vaccine Product Picture
Figure 13. Veterinary Vaccine Product Picture
Figure 14. Global Vaccine Adjuvants Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Vaccine Adjuvants Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Vaccine Adjuvants Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Vaccine Adjuvants Sales by Region in 2022
Figure 21. Global Vaccine Adjuvants Revenue by Region in 2022
Figure 22. North America Vaccine Adjuvants Market Size by Country in 2022
Figure 23. North America Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 24. North America Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Vaccine Adjuvants Market Size by Country in 2022
Figure 28. Europe Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 29. Europe Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 30. Germany Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Vaccine Adjuvants Market Size by Country in 2022
Figure 36. Asia Pacific Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 38. China Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Vaccine Adjuvants Market Size by Country in 2022
Figure 48. Latin America Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 49. Latin America Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Vaccine Adjuvants Market Size by Country in 2022
Figure 54. Middle East and Africa Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Vaccine Adjuvants Sales Market Share by Type (2018-2029)
Figure 60. Global Vaccine Adjuvants Revenue Market Share by Type (2018-2029)
Figure 61. Global Vaccine Adjuvants Price (USD/Kg) by Type (2018-2029)
Figure 62. Global Vaccine Adjuvants Sales Market Share by Application (2018-2029)
Figure 63. Global Vaccine Adjuvants Revenue Market Share by Application (2018-2029)
Figure 64. Global Vaccine Adjuvants Price (USD/Kg) by Application (2018-2029)
Figure 65. Vaccine Adjuvants Value Chain
Figure 66. Vaccine Adjuvants Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Vaccine Adjuvants Industry Opportunities and Challenges
